Document Detail

Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability.
MedLine Citation:
PMID:  25382205     Owner:  NLM     Status:  Publisher    
Atherosclerosis is the main pathophysiological process underlying acute cardiovascular diseases. Life-threatening conditions, such as myocardial infarction and ischemic stroke, are provoked by the sudden rupture of vulnerable atherosclerotic plaques, characterized by thin, highly inflamed and collagen-poor fibrous cap. Whereas both innate and adaptive inflammation progressively emerged as driving force of this processes, less is known about the involvement of neutrophils (PMNs). Advances in laboratory techniques during the last two decades disclosed that PMNs play a crucial role in promoting plaque vulnerability by the release of different enzymes, such as gelatinases (matrix metalloproteinases) collagenases, elastase and myeloperoxidase. Accordingly, circulating levels of PMNs and their products have been investigated as potential markers of plaque instability in both primary and secondary prevention on cardiovascular diseases. In addition, the development of different classes of drugs targeting PMNs activation is emerging as an interesting field of research. This narrative review will provide an update on the role of PMNs in promoting plaque vulnerability also discussing the potential effects of therapeutic strategies targeting PMN on plaque vulnerability.
Federico Carbone; François Mach; Fabrizio Montecucco
Related Documents :
16186055 - Transplant coronary artery disease: incidence, progression and interventional revascula...
16847655 - Accuracy of non-invasive techniques for diagnosis of coronary artery disease and predic...
14612215 - Plasma osteopontin levels are associated with the presence and extent of coronary arter...
14752485 - Relationship between the ischemic threshold at the onset of wall-motion abnormality on ...
10453605 - A comparative observation on treatment of heart failure due to diastolic insufficiency ...
12968835 - Qtc prolongation due to propranolol overdose.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-11-09
Journal Detail:
Title:  Current drug targets     Volume:  -     ISSN:  1873-5592     ISO Abbreviation:  Curr Drug Targets     Publication Date:  2014 Nov 
Date Detail:
Created Date:  2014-11-10     Completed Date:  -     Revised Date:  2014-11-11    
Medline Journal Info:
Nlm Unique ID:  100960531     Medline TA:  Curr Drug Targets     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Targeting the Ataxia Telangiectasia Mutated protein in cancer therapy.
Next Document:  The role of adipocytokines in atherogenesis and atheroprogression.